Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Nohandledzepon Mar 11, 2014 1:50pm
156 Views
Post# 22308935

RE:TOO BAD they're so modest..

RE:TOO BAD they're so modest..One would assume that a company with a share price collapsing might make the two analyst reports readily available.

I was told by my broker that the reason they haven't is that they have been posted several times on "stock boards" and any form of self promotion might be considered untoward. Hmmm, I have never seen a link for either report posted and I am not sure what could be more untoward than a stock with a 1 year target of $5 trading below 25 cents?

And what about the 80% of retail shareholders who don't bother reading these things...were they just excluded altogether?

It seems incredibly obvious that the Spectral has no interest in promoting itself, let alone providing access to credible and optimistic third party coverage of the company for current shareholders.

The only conclusion I can draw is that the interim P3 results are incredibly bad and they don't want to encourage any new buying to protect their current shareholders from themselves prior to the impending trial cancellation.
Bullboard Posts